Evidence map›Paper›PMID 39172143›Full record

ArticleArchives of toxicology2024

Genotoxicity of selected cannabinoids in human lymphoblastoid TK6 cells.

Nicol Kolar, Ezgi Eyluel Bankoglu, Helga Stopper

Abstract read
In one paragraph

Article in Archives of toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. ComparativeFrontiers in toxicology · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicol KolarInstitute of Pharmacology and Toxicology, University of Wuerzburg, 97078, Würzburg, Germany.
Ezgi Eyluel BankogluInstitute of Pharmacology and Toxicology, University of Wuerzburg, 97078, Würzburg, Germany.ORCID 0000-0001-7488-6228
Helga StopperInstitute of Pharmacology and Toxicology, University of Wuerzburg, 97078, Würzburg, Germany. helga.stopper@uni-wuerzburg.de.ORCID 0000-0003-4168-8211

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural non-psychoactive cannabinoids such as cannabigerol (CBG), cannabidiol (CBD), cannabichromene (CBC), cannabidivarin (CBDV), and cannabinol (CBN) are increasingly consumed as constituents of dietary products because of the health benefits claims. Cannabinoids may reduce certain types of pain, nausea, and anxiety. Anti-inflammatory and even anti-carcinogenic properties have been discussed. However, there are insufficient data available regarding their potential (geno-)toxic effects. Therefore, we tested CBG, CBD, CBC, CBDV, and CBN for their genotoxic potential and effects on mitosis and cell cycle in human lymphoblastoid TK6 cells. The selected cannabinoids (except CBDV) induced increased micronuclei formation, which was reduced with the addition of a metabolic activation system (S9 mix). CBDV induced micronuclei only after metabolic activation. Mitotic disturbances were observed with all tested cannabinoids, while G1 phase accumulation of cells was observed for CBG, CBD and CBDV. The genotoxic effects occurred at about 1000-fold higher concentrations than are reported as blood levels from human consumption. However, the results clearly indicate a need for further research into the genotoxic effects of cannabinoids. The mechanism of the mitotic disturbance, the shape of the dose-response curves and the possible effects of mixtures of cannabinoids are aspects which need clarification.

Indexed as

CannabinoidsLymphocytesMicronucleus TestsMitosisMutagensCannabidiolCell CycleCell LineDNA DamageDose-Response Relationship, DrugHumansMicronuclei, Chromosome-DefectiveMutagenicity TestsCannabidiolcannabidivarinCannabinoidsMutagensCannabichromeneCannabidiolCannabidivarinCannabigerolCannabinolGenotoxicityMicronuclei

Identifiers

PMID39172143
PMCPMC11402852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.